4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-009368
General Counsel sold 90,000 shares at an average $88.46 ($7,961,240)
- General Counsel acquired 90,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Brien Patrick General Counsel | 2021-02-08 | Option exercise | +90,000 | $5.22 | $469,800 | 383,375 | D |
| O'Brien Patrick General Counsel | 2021-02-08 | Sale | −7,961 | $86.72 | $690,378 | 375,414 | D |
| O'Brien Patrick General Counsel | 2021-02-08 | Sale | −31,255 | $88.08 | $2,752,940 | 344,159 | D |
| O'Brien Patrick General Counsel | 2021-02-08 | Sale | −45,348 | $88.88 | $4,030,530 | 298,811 | D |
| O'Brien Patrick General Counsel | 2021-02-08 | Sale | −5,436 | $89.66 | $487,392 | 293,375 | D |
| Derivatives | |||||||
| O'Brien Patrick General Counsel | 2021-02-08 | Option exercise · Stock Option (right to buy) | −90,000 | 60,000 | D | ||
| Open-market sales · 90,000 sh · avg $88.46 · $7,961,240 | |||||||
Loading xslF345X03/doc4.xml…